Innovative medicines are launched sooner than non-innovative ones irrespective of patent regimes. Using launch data from 1980 to 2017, we find that introducing product patents is important for innovative medicines by speeding up their launch by 14 percent. Our data from IQVIA covers 578 molecules in 70 countries. This paper analyses the impact of patents on the availability and affordability of new and innovative medicines in a post-TRIPS era. ![]() ![]() ![]() Enacted in 1995, the Agreement on Trade-Related Aspects of Intellectual Property Rights of the World Trade Organisation makes it obligatory for member states to protect pharmaceutical product patents, which has great impacts on global access to medicines.
0 Comments
Leave a Reply. |